Abstract Objectives: The OPTION (Optimal Anti-Tachycardia Therapy in Implantable
Cardioverter-Defibrillator Patients Without Pacing Indications) trial sought to compare long …

Aims To evaluate the incidences of and risk factors predisposing to appropriate and
inappropriate shocks and mortality in a 'real-world'population of patients with ischaemic …

Life-saving shocks are the raisons d'être of implantable cardioverter-defibrillators (ICDs).
Paradoxically, shocks also cause much of the morbidity associated with ICDs. Consistently …

Aims Implantable cardioverter defibrillator (ICD) technology has become more complex,
particularly with respect to biventricular resynchronization devices. The incidence of …

Background Inappropriate implantable cardioverter-defibrillator (ICD) shocks are a common
and significant problem in pediatric patients and patients with congenital heart disease …

Aims Dual-chamber implantable cardioverter-defibrillators (ICDs) may improve specificity
and reduce the risk of inappropriate shocks, and enhance atrial arrhythmia (AT/AF) detection …

Abstract Aims Implantable cardioverter-defibrillators (ICDs) are key in the prevention of
sudden cardiac death, but outcomes may vary by type of device or programming [single …

In a contemporary setting, where the risk of sudden cardiac death (SCD) is low, heart failure
management is improved, and technology is advanced, identifying the patients who would …

Background In US clinical practice, many patients who undergo placement of an implantable
cardioverter‐defibrillator (ICD) for primary prevention of sudden cardiac death receive dual …

Background Pacing in the right ventricle can cause a variety of detrimental effects, including
atrial tachyarrhythmias (atrial tachycardia [AT]/atrial fibrillation [AF]). Objective The purpose …